PMID- 16331364
OWN - NLM
STAT- MEDLINE
DCOM- 20060518
LR  - 20151119
IS  - 0340-9937 (Print)
IS  - 0340-9937 (Linking)
VI  - 30
IP  - 8
DP  - 2005 Dec
TI  - [Actual clinical practice of guideline-recommended therapy of acute ST elevation 
      myocardial infarction].
PG  - 700-3
AB  - Treatment of acute ST elevation myocardial infarction (STEMI) is based on early 
      reperfusion therapy (primary PCI [percutaneous coronary intervention], 
      thrombolysis) and adjunctive medical therapy. Primary PCI is recommended as the 
      therapy of first choice in the German guidelines, if the delay by a transfer to 
      primary PCI versus thrombolysis is <or=90 min. Actual treatment of STEMI in 
      clinical practice was analyzed by the Ludwigshafen myocardial infarction 
      registries. The Ludwigshafen myocardial infarction registries are prospective 
      multicenter registries including approximately 60,000 consecutive patients in the 
      last 13 years. The mean prehospital delay of STEMI patients in Germany is 190 
      min. To reduce this critical time delay, intensive and continuous education of 
      the patients is necessary. The rate of early reperfusion therapy of STEMI 
      patients in Germany is 60-70%; especially the rate of primary PCI clearly 
      increased in comparison to former published data. Patients without reperfusion 
      therapy have a very high mortality. Physicians therefore should try to further 
      improve the rate of early reperfusion therapy in STEMI patients. Medical 
      adjunctive treatment should be used to a high dose in every STEMI patient without 
      individual contraindications.
FAU - Wienbergen, Harm
AU  - Wienbergen H
AD  - Herzzentrum, Medizinische Klinik B, Institut fur Herzinfarktforschung, 
      Ludwigshafen. wienberh@klilu.de
FAU - Gitt, Anselm K
AU  - Gitt AK
FAU - Senges, Jochen
AU  - Senges J
LA  - ger
PT  - English Abstract
PT  - Journal Article
TT  - Aktuelle Umsetzung der leitlinienkonformen Therapie des akuten ST-Hebungsinfarkts 
      in Deutschland.
PL  - Germany
TA  - Herz
JT  - Herz
JID - 7801231
RN  - 0 (Fibrinolytic Agents)
SB  - IM
MH  - Angioplasty, Balloon, Coronary/*statistics & numerical data
MH  - Emergency Medical Services/statistics & numerical data
MH  - Fibrinolytic Agents/*administration & dosage
MH  - Germany/epidemiology
MH  - Hospitalization/statistics & numerical data
MH  - Humans
MH  - Myocardial Infarction/*epidemiology/*therapy
MH  - *Practice Guidelines as Topic
MH  - Practice Patterns, Physicians'/standards
MH  - Prognosis
MH  - *Registries
MH  - Thrombolytic Therapy/*statistics & numerical data
MH  - Treatment Outcome
EDAT- 2005/12/07 09:00
MHDA- 2006/05/19 09:00
CRDT- 2005/12/07 09:00
PHST- 2005/12/07 09:00 [pubmed]
PHST- 2006/05/19 09:00 [medline]
PHST- 2005/12/07 09:00 [entrez]
AID - 10.1007/s00059-005-2757-7 [doi]
PST - ppublish
SO  - Herz. 2005 Dec;30(8):700-3. doi: 10.1007/s00059-005-2757-7.